匯頂科技(603160.SH)漲近8% 超薄屏下光學指紋方案正式商用於5G終端
格隆匯12月9日丨匯頂科技(603160.SH)今日大漲,現報214.62元,漲7.9%,暫成交7.9億元,最新總市值979億元。一加7T Pro 5G 邁凱倫版通過運營商T-Mobile的美國銷售網絡正式開售,據瞭解,這是全球首款搭載超薄屏下光學指紋方案的5G手機。據悉,該超薄屏下光學指紋方案由匯頂科技(603160)提供,表明匯頂科技超薄屏下光學指紋方案正式規模商用於5G終端。另外,12月5日,匯頂科技公告近日收到國家市場監管局下達的《經營者集中反壟斷審查不予禁止決定書》,表示對公司收購恩智浦VAS業務不予禁止。國內反壟斷通過,意味着邁出併購VAS第一步。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.